Immucell (ICCC) Finished Goods (2018 - 2026)
Immucell's (ICCC) quarterly Finished Goods came in at $1.9 million in Q4 2025, up 19498.13% YoY from N/an in Q4 2024, and down 5.53% on a QoQ basis from $2.0 million in Q3 2025.
Immucell (ICCC) Finished Goods (2018 - 2026) Analysis & Trends
Immucell (ICCC) has 8 years of Finished Goods data on file, last reported at $1.9 million in Q4 2025.
- Quarterly Finished Goods rose 19498.13% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (up 19498.13% YoY) and the FY2025 annual result came in at $1.9 million, up 19498.13% from the prior year.
- Finished Goods slipped to $1.9 million in Q4 2025, from $2.0 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $2.0 million in Q3 2025 to a low of $9530.0 in Q4 2024.
- A 5-year average of $569077.0 and a median of $402619.0 in 2023 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2024 — Finished Goods tumbled 97.63% — and 2025, when it surged 19498.13%.
- Tracing ICCC's Finished Goods over 5 years: stood at $29381.0 in 2021, then soared by 410.04% to $149855.0 in 2022, then jumped by 168.67% to $402619.0 in 2023, then plunged by 97.63% to $9530.0 in 2024, then surged by 19498.13% to $1.9 million in 2025.
- The last three Finished Goods figures came in at $1.9 million (Q4 2025), $2.0 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 40,747.00 |
| Dec 31, 2024 | 9,530.00 |
| Sep 30, 2024 | 22,292.00 |
| Jun 30, 2024 | 440,858.00 |
| Mar 31, 2024 | 369,003.00 |
| Dec 31, 2023 | 402,619.00 |
| Sep 30, 2023 | 425,604.00 |
| Jun 30, 2023 | 466,069.00 |
| Dec 31, 2022 | 149,855.00 |
| Mar 31, 2021 | 29,381.00 |
| Dec 31, 2020 | 23,013.00 |
| Sep 30, 2020 | 223,928.00 |
| Jun 30, 2020 | 31,878.00 |
| Mar 31, 2020 | 162,349.00 |
| Dec 31, 2019 | 519,241.00 |
| Sep 30, 2019 | 856,336.00 |